Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-001596

ChemoCentryx, Inc. · CCXI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Rajinder Singh
Officer — SVP, Research
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 8:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 1, 2019M10,000$0.00A14,330D
Common StockJan 1, 2019M5,000$0.00A19,330D
Common StockF3Jan 1, 2019F8,716$10.91D10,614D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F5—Jan 1, 2019M10,000D——Common Stock10,00010,000D
Restricted Stock UnitsF4,F6—Jan 1, 2019M5,000D——Common Stock5,00010,000D

Explanation of responses